SITC Cancer Immunotherapy CONNECT

SITC Statement on NIH Cuts to Indirect Costs

Browse our other events

2025 ACI

2025 ACI: A Focus on Women's Malignancies

Feb. 28, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Access current updates in the use of immunotherapies to treat early-stage and late-stage breast cancer. Join SITC and a panel of clinical experts!

Learn More
2025 Spring Scientific

2025 Spring Scientific: Cellular Therapy for Solid Tumors

March 12–14, 2025 in San Diego, CA
& Virtually

SITC will bring the brightest minds and the next generation of leaders together to explore promising science and develop novel opportunities to challenges that impede bringing these novel therapies to patients in need.

Register Today



2025 Deep Dive

Targets for Cancer IO: A Deep Dive Series 5

SITC is pleased to announce our fifth Targets for Cancer IO: A Deep Dive live webinar series. Expert leaders in their fields will provide an overview of the current state of the science and address questions about its future. An interactive Q&A session will follow the topic overview.

Register Now


2024 Medlive

SITC Summit on Neuro Immuno-Oncology: From Challenges to Opportunities

Wed., Feb. 19, 2025 - 124 p.m. EDT

This summit will highlight translational and clinical research in neuro immuno-oncology, areas of opportunity and development in the field, and how this novel research will advance the use of immunotherapy to treat brain tumors.

Register Now
2025 ACI

2025 ACI: A Focus on Toxicity Management

March 7, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Address insights on adverse events and autoimmunity, as well as the management of hyperinflammatory systems. Join SITC and a panel of clinical experts!

Learn More
2025 IO360

2025 Immuno-Oncology 360°

March 24–26, 2025 | Boston, MA

Explore the latest developments in cancer immunotherapy presented by SITC and the Conference Forum at the Immuno-Oncology 360° Summit March 24–26. Key topics include biomarkers, IO combinations, cell therapy and ADCs, & more! SITC members use code SITC20 for 20% of registration.

REGISTER
2025 ACI

2025 ACI: A Focus on Bladder & Genitourinary Cancers

April 7, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Discuss immune checkpoint inhibitor rechallenge for management of bladder and genitourinary cancers. Gain in-depth clinical education from leading experts!

Register now
2025 ACI

2025 ACI: A Focus on Gastrointestinal Cancers

April 23, 2025 | 1–5 p.m. EDT | Virtual

Discuss recent developments and ongoing studies of adoptive cellular therapies for gastrointestinal cancers. Improve patient outcomes with cutting-edge insights from clinical experts!

Register now
2025 ACI

2025 ACI: A Focus on Intratumoral Therapies, Vaccines and Cytokines

May 8, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of intratumoral therapies, vaccines, & cytokines!

Register now
2025 ACI

2025 ACI: A Focus on Cellular Therapies, T Cell Engagers and TIL Therapies

June 27, 2025 | 11 a.m.–3 p.m. EDT | Virtual

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of cellular therapies, T cell engagers and TIL Therapies. 

Register now

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

 Upcoming SITC Events


 Read the Latest SITC News

JITC Digest January 2025

INSIDE THIS ISSUE: Letter from the Editor | JITC Editor ...
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, ...

Immune Monitor - December 2024

A Message from the President Over the last 12 months, you collectively dedicated your creativity, ...

 Latest Discussions

  • NCI Virtual Workshop - In Vivo Engineering of Immune Cells ( IVEIC ) for Cancer ...

    3 people like this.
  • The abstract submission site is NOW OPEN for 2025 SITC Spring Scientific ...

  • 2024 IOTOX Symposium

    The MD Anderson Internal Medicine Division and Cancer Medicine Division are ...

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

 Join the SITC Family